(Q37989562)

English

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

scientific article published on 02 March 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

0 references

allergic bronchopulmonary aspergillosis

0 references

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

David W. Denning

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

object named as

Robert M Niven

2

0 references

author name string

Livingstone Chishimba

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

John Cooley

3

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

language of work or name

0 references

publication date

2 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

423-433

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

The link between fungi and severe asthma: a summary of the evidence.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Severe asthma with fungal sensitization: a case report and review of literature

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Pathology of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Allergic bronchopulmonary aspergillosis: a rare cause of pleural effusion

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Relationships between prednisone therapy, disease activity, and the total serum IgE level in allergic bronchopulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Antifungals in the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Adverse events associated with itraconazole in 189 patients on chronic therapy.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Heart failure induced by non-cardiac drugs

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Voriconazole therapy in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Antifungal therapeutic drug monitoring: established and emerging indications

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Asthma control versus asthma severity

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Control of asthma

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Global strategy for asthma management and prevention: GINA executive summary.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Classification of asthma according to revised 2006 GINA: evolution from severity to control

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Severe asthma in adults

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Summary of the 2008 BTS/SIGN British Guideline on the management of asthma.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

1998 revision of the Canadian Asthma Consensus Guidelines. Asthma Consensus Conference Editorial Committee

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Airway remodeling contributes to the progressive loss of lung function in asthma: an overview

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Phototoxicity and photocarcinogenesis associated with voriconazole.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers.

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Peripheral neuropathy in patients on long-term triazole antifungal therapy

1 reference

https://api.crossref.org/works/10.3109%2F02770903.2012.662568

21 January 2018

Identifiers

10.3109/02770903.2012.662568

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37989562&oldid=2170914260"